Start › Rak jelita grubego i odbytnicy › Maryland › Baltimore
Badania kliniczne dla Rak jelita grubego i odbytnicy w mieście Baltimore, MD
31 badań dla Rak jelita grubego i odbytnicy szuka uczestników w ośrodkach w mieście Baltimore i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Family Communications After Genetic Testing
RekrutacjaZapraszamy zdrowych ochotników
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · 8 mi dalej
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- i 2 więcej
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekrutacjaFaza 1
- Exelixis Clinical Site #14, Baltimore
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekrutacjaFaza 3
- Greater Baltimore Medical Center, Baltimore
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RekrutacjaFaza 3
- MedStar Franklin Square Medical Center, Baltimore
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RekrutacjaFaza 3
- MedStar Franklin Square Medical Center, Baltimore
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RekrutacjaFaza 2/3
- Local Institution - 0262, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekrutacjaFaza 1
- United Theranostics, Glen Burnie · 9 mi dalej
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekrutacjaFaza 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekrutacjaFaza 1
- Johns Hopkins, Baltimore
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekrutacjaFaza 3
- Saint Agnes Hospital, Baltimore
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
RekrutacjaFaza 1
- United Theranostics, Glen Burnie · 9 mi dalej
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
RekrutacjaFaza 1/2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RekrutacjaFaza 3
- Clinical Study Site, Baltimore
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
RekrutacjaFaza 2
- Research Site, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
RekrutacjaFaza 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekrutacjaFaza 1
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekrutacjaFaza 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
RekrutacjaFaza 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RekrutacjaFaza 2
- Johns Hopkins Hospital /ID# 275645, Baltimore
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
RekrutacjaFaza 4
- Mercy Medical Center, Baltimore
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Rekrutacja
- Johns Hopkins University, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RekrutacjaFaza 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi dalej
- United Theranostics - Chesapeake, Glen Burnie · 9 mi dalej
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekrutacjaFaza 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RekrutacjaFaza 1/2
- Johns Hopkins Hospital, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekrutacjaFaza 1/2
- Johns Hopkins University, Baltimore
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
RekrutacjaFaza 2
- Johns Hopkins SKCCC, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekrutacjaFaza 1/2
- Johns Hopkins University, Baltimore
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
RekrutacjaFaza 2
- NGM Clinical Study Site, Baltimore
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekrutacjaBadanie obserwacyjne
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · 8 mi dalej
- i 1 więcej
Badania dla Rak jelita grubego i odbytnicy w innych miastach
- Houston, TX102 badań
- New York City, NY78 badań
- Nashville, TN69 badań
- Boston, MA63 badań
- Los Angeles, CA59 badań
- Arlington, VA52 badań
- St. Louis, MO50 badań
- San Antonio, TX46 badań
- Philadelphia, PA44 badań
- Grand Rapids, MI40 badań
- Baldwin Park, CA37 badań
- Chicago, IL34 badań
Inne badania w mieście Baltimore
- Niedrobnokomórkowy rak płuca60 badań
- Rak piersi47 badań
- Rak prostaty43 badań
- Rak płuc40 badań
- Nowotwory (wszystkie typy)37 badań
- Rak trzustki31 badań
- Nowotwór przerzutowy28 badań
- Otyłość26 badań
- Rak pęcherza moczowego24 badań
- Niewydolność serca24 badań
- Rak jajnika22 badań
- Udar21 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.